PlainRecalls
FDA Drug Critical Class I Terminated

SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.

Reported: April 13, 2022 Initiated: March 21, 2022 #D-0764-2022

Product Description

SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.

Reason for Recall

Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

Details

Units Affected
2,500 cartons
Distribution
Nationwide in the U.S.A.
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.. Recalled by Adamis Pharmaceuticals Corporation. Units affected: 2,500 cartons.
Why was this product recalled?
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 13, 2022. Severity: Critical. Recall number: D-0764-2022.